These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39143779)

  • 1. [Resistant hypertension and the risk of major adverse cardiac and cerebrovascular events in outpatients].
    Xia JH; Wang XY; Kang YY; Huang JF; Guo QH; Cheng YB; Li Y; Wang JG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Aug; 52(8):884-891. PubMed ID: 39143779
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study.
    Cardoso CRL; Salles GF
    J Am Heart Assoc; 2020 Sep; 9(17):e017634. PubMed ID: 32851922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
    Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
    J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia is an independent risk factor for cardiovascular and renal events in hypertensive outpatients with well-controlled blood pressure: a subgroup analysis of the ATTEMPT-CVD randomized trial.
    Kim-Mitsuyama S; Soejima H; Yasuda O; Node K; Jinnouchi H; Yamamoto E; Sekigami T; Ogawa H; Matsui K
    Hypertens Res; 2019 Jun; 42(6):883-891. PubMed ID: 30664702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent resistant hypertension and the risk of vascular events and mortality in patients with manifest vascular disease.
    van der Sande NGC; de Beus E; Bots ML; Voskuil M; Blankestijn PJ; Visseren F; Spiering W;
    J Hypertens; 2018 Jan; 36(1):143-150. PubMed ID: 28763342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal denervation for resistant hypertension.
    Coppolino G; Pisano A; Rivoli L; Bolignano D
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011499. PubMed ID: 28220472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population.
    Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; de Leeuw PW; Jaaskivi M; Nachev C; Parati G; O'Brien ET; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH;
    J Hypertens; 2003 Dec; 21(12):2251-7. PubMed ID: 14654744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients.
    Chun KH; Lee CJ; Oh J; Lee SH; Kang SM; Kario K; Park S
    J Clin Hypertens (Greenwich); 2020 Nov; 22(11):2093-2102. PubMed ID: 32951267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The 10-year stroke risk in hypertensive outpatients combined with diabetes in cardiovascular clinics of 36 tertiary hospitals in China].
    Bao B; Zhou Y; Liu J; Huo Y
    Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):941-6. PubMed ID: 25623559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure.
    Zhang DY; Guo QH; An DW; Li Y; Wang JG
    J Hypertens; 2019 Sep; 37(9):1775-1785. PubMed ID: 31219948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients.
    De Nicola L; Gabbai FB; Agarwal R; Chiodini P; Borrelli S; Bellizzi V; Nappi F; Conte G; Minutolo R
    J Am Coll Cardiol; 2013 Jun; 61(24):2461-2467. PubMed ID: 23623908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.
    Fujiwara T; Yano Y; Hoshide S; Kanegae H; Kario K
    JAMA Cardiol; 2018 Jul; 3(7):583-590. PubMed ID: 29800067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure targets for hypertension in older adults.
    Garrison SR; Kolber MR; Korownyk CS; McCracken RK; Heran BS; Allan GM
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011575. PubMed ID: 28787537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
    Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
    J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of masked uncontrolled apparent resistant hypertension detected through home blood pressure monitoring.
    Barochiner J; Aparicio LS; Martínez R; Alfie J; Marín MJ
    J Hypertens; 2021 Nov; 39(11):2141-2146. PubMed ID: 34128493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.